Susanna Fletcher Greer: Stories Like This Beautiful One Stay With Me

Maite Bourlon: Happy to be ASCO Voice at This ASCO GU 2026

Deepti Sharma: A Global Collaborative Forum on Cancer Care

Biopharma Faces Revenue Squeeze as 275 Billion Dollars at Risks

Margaret Foti: Grateful to Congress for Supporting NIH and NCI

Oncology News, Insights, Stories by OncoDaily

FDA approval BRAFTOVI
FDA Approvals

FDA Grants Full Approval of BRAFTOVI Combination Regimen in 1L Metastatic Colorectal Cancer

CheckMate 743 Five-Year Update: Nivolumab Plus Ipilimumab Maintains Long-Term Survival Benefit in Unresectable Pleural Mesothelioma
New Paper Alert

CheckMate 743 Five-Year Update: Nivolumab Plus Ipilimumab Maintains Long-Term Survival Benefit in Unresectable Pleural Mesothelioma

Bishal Gyawali
Voices

Bishal Gyawali: ASCO Guidelines Shaped Me - Now I Help Shape What’s Next

Neeraj Agarwal on ASCO GU 2026: Survival Signals, Biomarkers, and the Future of GU Trials Part 1

Patrick Soon-Shiong About the Breakthrough BioShield Approach to Cancer Treatment

Sibylle Loibl: Important Data for HR+/ HER2+ Metastatic Breast Cancer

Why Lung Cancer Patients Feel Worse at Night: Sleep, Anxiety and Breathing Explained

Nazik Hammad Reflects on a Century of African Medical Education with E.Oluwabunmi Olapade-Olaopa

ECHoS calls for a bold move to Accelerate Europe’s Fight Against Cancer in the next Framework Programme (FP10)

Sultan Stambekov: Special Recognition to Our First Lady for Her Immense Contribution to Advancing Care for Children with Cancer

Cervical Cancer 2026
OncoThon 2026
Advances in The Immunotherapy of Cold Tumors
OncoDaily 100
Act 4 Children
Grand Rounds GI
OncoDaily Party: Berlin 2025
awards
awards
awards
awards
awards
awards

Voices
Bishal Gyawali

Bishal Gyawali: ASCO Guidelines Shaped Me - Now I Help Shape What’s Next

Neeraj Agarwal on ASCO GU 2026: Survival Signals, Biomarkers, and the Future of GU Trials Part 1

Joshua Omale: Turning Cancer Innovation Into Real Impact Through System Readiness

Mike Kinnaird: Speaking Out on What’s Hidden in Cancer Funding Decisions

Joshua Budhu: Excited to Share Our New Review on Financial Toxicity in Cancer Care

Join the Leading Event for Innovation in Pathology 2026 - European Society of Pathology

The Multinational Association of Supportive Care in Cancer Calls to Join Their Webinar

FDA Approvals
FDA approval BRAFTOVI

FDA Grants Full Approval of BRAFTOVI Combination Regimen in 1L Metastatic Colorectal Cancer

FDA Approves Combination Treatment of VENCLEXTA (venetoclax) and Acalabrutinib for Previously Untreated Patients With CLL

Monthly RYBREVANT FASPRO (Amivantamab) Approved by FDA for EGFR-Mutated NSCLC

PANOVA-3 Leads to FDA Approval of Optune Pax in Locally Advanced Pancreatic Cancer

Abbisko Therapeutics’ FGFR4 Inhibitor Irpagratinib Receives FDA Fast Track Designation in FGF19-Overexpressing Advanced HCC

Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy

OncoDaily 100
100 Most Influential CEOs

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

Southern Florida Psychiatry Conference 2026

Physicians’ Education Resource

04 Dec
Psychiatry

24th Annual Winter Lung Cancer Conference 2027

Physicians’ Education Resource

29 Jan
Lung Cancer

3rd Annual Hawaii Cancer Conference

Physicians’ Education Resource

23 Jan
Hawaii

43rd Annual Miami Breast Cancer Conference

Physicians’ Education Resource

05 Mar
Breast Cancer

Beyond the NGS Report: Practical Interpretation for Lung Cancer Care

Thoracic Oncology Group of Australasia

28 Apr
Lung Cancer

Immune-oncology
10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

The Myth of Lifelong Immunotherapy: Is It Safe to Stop Treatment After Response?

10 Must-Read Posts in Immuno-Oncology This Week

Positive Topline Results from Phase 3 RINGSIDE Trial: Varegacestat Significantly Improves Outcomes in Desmoid Tumors

How Do Pharmacists Protect the Safety and Effectiveness of Immunotherapy?

10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

OncoDaily TV
The Breast Friends Podcast

Why Hasn’t Immunotherapy Consistently Delivered in HER2+ Disease? – The Breast Friends

Childhood Cancer

Saving One Million Children: WHO’s Global Initiative for Childhood Cancer with Dr. Catherine Lam

Jeffrey Bluestone

Inside the Mind of Jeffrey Bluestone: Lessons From a Lifetime in Immunology

Princess Dina Mired and Gevorg Tamamyan

Global Health Dialogues with Princess Dina Mired: Dr. Gevorg Tamamyan

Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

minister

When Minister is also your treating Doctor – Hosams Abu Meri

Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Dr. Navid Madani

Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Prof. Kofi Mensah Nyarko

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Mina S. Sedrak

Mina S. Sedrak: Shaping the Future of Cancer and Aging Research, Redefining Survivorship

Yuman Fong

Yuman Fong: Exclusive Interview on Innovation, Mentorship and the Future of Surgical Oncology

Immunotherapy in Nigeria

Opening New Frontiers for Cancer Care in Africa: Bringing Colorectal Cancer Immunotherapy in Nigeria

Not To Miss
Funding

Top 10 OncoGrants This Week: Horizon Europe €35M Calls, Seed Funding & Venture Competitions (2026)

Oncology This Week: OncoDaily Weekly Feb 16-22, 2026

Oncology This Week: OncoDaily Weekly Feb 9-15, 2026

ASH Highlights 2026: Insights from Dr Heghine Khachatryan

International Childhood Cancer Day 2026: Powerful Voices, Lifesaving Hope

International Day of Women and Girls in Science 2026

15 Posts Not To Miss from AMSTRO 2026

OncoGrants
Markey Cancer Survivorship Research Initiative Pilot Award

Markey Cancer Survivorship Research Initiative Pilot Award (Markey Cancer Center, University of Kentucky)

2026 Pilot Project Program (UAMS COBRE Center for Studies of Host Response to Cancer Therapy)

2026 Pilot Project Program (UAMS COBRE Center for Studies of Host Response to Cancer Therapy)

Ovarian Cancer Research Funding Opportunity FY 2026 Award Cycle (University of Colorado Cancer Center) — Team Science Awards

Ovarian Cancer Research Funding Opportunity FY 2026 Award Cycle (University of Colorado Cancer Center) — Team Science Awards

Ovarian Cancer Research Funding Opportunity FY 2026 Award Cycle (University of Colorado Cancer Center) — Collaborative Pilot Grants

Ovarian Cancer Research Funding Opportunity FY 2026 Award Cycle (University of Colorado Cancer Center) — Collaborative Pilot Grants

New Pilot Funding Opportunity in Colorectal Cancer (Johns Hopkins CRC CORE)

New Pilot Funding Opportunity in Colorectal Cancer (Johns Hopkins CRC CORE)

MCC Community Outreach and Engagement Partnership Planning Grant (Markey Cancer Center, University of Kentucky)

MCC Community Outreach and Engagement Partnership Planning Grant (Markey Cancer Center, University of Kentucky)

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologists
Melvin L.K. Chua

Melvin L.K. Chua

Oncologists Location Singapore, Singapore
Bahar Laderian

Bahar Laderian

Oncologists Location Bronx, USA
Iyad Sultan

Iyad Sultan

Oncologists Location Amman, Jordan
Jan Fagerberg

Jan Fagerberg

Oncologists Location Paris, France
Chandler Park

Chandler Park

Oncologists Location Louisville, USA
Ilya Tsimafeyeu

Ilya Tsimafeyeu

Oncologists Location Moscow, Russia
Robert E. Reiter

Robert E. Reiter

Oncologists Location Los Angeles, USA
Roupen Odabashian

Roupen Odabashian

Oncologists Location Detroit, USA

Oncology Drugs
Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

GSK5764227 (HS-20093): Clinical Development of a Next-Generation B7-H3 Directed Antibody–Drug Conjugate

Daraxonrasib (RMC-6236): Clinical Development of a RAS(ON) Inhibitor Advancing Precision Therapy in RAS-Driven Solid Tumors

Daraxonrasib (RMC-6236): A New Targeted Treatment Being Studied for RAS-Driven Cancers

Anbenitamab (KN026): A Patient-Friendly Guide to a New HER2-Targeted Treatment

OncoDaily Magazine
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

New Paper Alert
CheckMate 743 Five-Year Update: Nivolumab Plus Ipilimumab Maintains Long-Term Survival Benefit in Unresectable Pleural Mesothelioma

CheckMate 743 Five-Year Update: Nivolumab Plus Ipilimumab Maintains Long-Term Survival Benefit in Unresectable Pleural Mesothelioma

AXINET Trial

AXINET (GETNE-1107) Trial : Axitinib Plus Octreotide in Advanced Extrapancreatic NETs

SCREESCO Trial

SCREESCO Trial: Colonoscopy and FIT vs Usual Care in CRC Screening

KRAS G12D Drives Early TNFα-Mediated Niche Programming in Pancreatic Tumorigenesis

KRAS G12D Drives Early TNFα-Mediated Niche Programming in Pancreatic Tumorigenesis

CheckMate 649

CheckMate 649: 5-Year Results of First-Line Nivolumab Plus Chemotherapy in Advanced Gastric, GEJ, and Esophageal Adenocarcinoma

KEYNOTE-905/EV-303 Trial: Perioperative Enfortumab Vedotin and Pembrolizumab in Muscle-Invasive Bladder Cancer

KEYNOTE-905/EV-303 Trial: Perioperative Enfortumab Vedotin and Pembrolizumab in Muscle-Invasive Bladder Cancer

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-002-0204-6423

Extracorporeal membrane oxygenation in the management of oncologic critical illness
Review

Radiation Oncology

10.69690/ODMJ-018-3101-6699

Comparative Evaluation of DIR-Based Auto-Adaptive, Manual, and Semi-Automated Contouring for Pelvic OARs in Cervical Cancer Adaptive Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6997

Validity of 18F FDG-PET/CT in the Detection of Bone Marrow Disease in Hodgkin's and Non-Hodgkin's Lymphoma
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7103

Dosimetric Comparison of 5-, 7-, and 9-Field SIB-IMRT Plans in Prostate Cancer Using 100% Isodose-Based Target Evaluation
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6652

Radiation‐induced Lung Toxicity: A Crucial Problem in Thoracic Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7089

Hippocampus Sparing for Patients Undergoing Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma in Morocco: A Dosimetric Study
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6686

Optimizing Quality of Life in Cervical Cancer Survivors: A Comparative Study of Vaginal Doses Delivered Using Three HDR Brachytherapy Applicators
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6503

Assessment of MOSFET Detectors in In-Vivo Dosimetry for VMAT Total Body Irradiation
Abstracts